Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michael Vaezi"'
Autor:
Chandra Sekhar Yadavalli, Sathisha Upparahalli Venkateshaiah, Alok K. Verma, Chandrasekhar Kathera, Pearce S. Duncan, Michael Vaezi, Richard J. Paul, Anil Mishra
Publikováno v:
Cells, Vol 13, Iss 4, p 295 (2024)
Background and Aims: Ultrasonography has shown that eosinophils accumulate in each segment of the esophageal mucosa in human EoE, ultimately promoting esophageal motility dysfunction; however, no mechanistic evidence explains how or why this accumula
Externí odkaz:
https://doaj.org/article/9334025c69b54c3a9330954a246d26e4
Autor:
Elif Saritas Yuksel, Michael Vaezi
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 1112 (2012)
Gastroesophageal reflux is a common condition affecting many patients in different parts of the world. It usually presents with the classic manifestations of heartburn and regurgitation; however, in some it can also present with extraesophageal manif
Externí odkaz:
https://doaj.org/article/4c39255374264107a71acb1e370b09be
Autor:
Rena Yadlapati, C. Prakash Gyawali, Dustin A. Carlson, John E. Pandolfino, Ronnie Fass, Abraham Khan, Haiying Lin, Joel E. Richter, Marcelo F. Vela, Michael Vaezi, John O. Clarke
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility SocietyREFERENCES.
The functional lumen imaging probe (FLIP) evaluates esophagogastric junction (EGJ) opening and esophageal contractility. Both post hoc and real-time analyses are possible, but reproducibility and reliability of analysis remain undefined. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6df438bc52b49570eae508f5e48f34c4
https://pubmed.ncbi.nlm.nih.gov/36480408
https://pubmed.ncbi.nlm.nih.gov/36480408
Autor:
John E. Pandolfino, Dustin A. Carlson, Josie McGarva, Peter J. Kahrilas, Michael Vaezi, David Katzka, Tiffany H. Taft
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 56(10)
Achalasia is a debilitating major motor disorder of the oesophagus. Hypervigilance and symptom-specific anxiety substantially impact dysphagia symptom reporting, and quality of life is a critical patient outcome. Earlier achalasia symptom scales did
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8c2aae20358f2ccacf23de693354909
https://pubmed.ncbi.nlm.nih.gov/36127750
https://pubmed.ncbi.nlm.nih.gov/36127750
The authors have requested that this preprint be removed from Research Square.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a37196c20e1cdbb3221787bd1ceba6d
https://doi.org/10.21203/rs.3.rs-857928/v1
https://doi.org/10.21203/rs.3.rs-857928/v1
Autor:
Peter V. Dicpinigaitis, Jaclyn A. Smith, Melanie Wosnitza, Lorcan McGarvey, Alyn H. Morice, Laurent Guilleminault, Mandel Sher, Riitta Saarinen, Philippe Vieira Pires, Akio Niimi, Katrin Roth, Michael Vaezi
Publikováno v:
Airway pharmacology and treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b35006658791b43992b8afee1e268d6
https://doi.org/10.1183/13993003.congress-2021.pa562
https://doi.org/10.1183/13993003.congress-2021.pa562
Autor:
Pritesh R, Mutha, Matthew, Fasullo, Shijian, Chu, Mitchell L, Schubert, Alvin, Zfass, Patricia, Cooper, Mankanchan, Gill, Le, Kang, Michael, Vaezi, Stu, Wildhorn, Chris, Slaughter, Tilak, Shah
Publikováno v:
Digestive diseases and sciences. 67(5)
Epithelial barrier function (EBF) disruption is a key mechanism underlying gastroesophageal reflux disease (GERD). Our aim was to assess whether two novel technologies, probe-based confocal laser endomicroscopy (pCLE) and mucosal integrity testing (M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e18c5644f9e41912c23d01731783296f
https://pubmed.ncbi.nlm.nih.gov/33939145
https://pubmed.ncbi.nlm.nih.gov/33939145
Obesity and Esophageal Disorders is a comprehensive review on the impact of obesity on esophageal disorders and how to approach, recognize and treat those disorders. Covering the critical gap in awareness on the impact of obesity on esophageal disord
Autor:
Evan S. Dellon, David A. Katzka, Margaret H. Collins, Mohamed Hamdani, Sandeep K. Gupta, Ikuo Hirano, Amir Kagalwalla, Jeffrey Lewis, Jonathan Markowitz, Samuel Nurko, John Wo, Evan Dellon, Thirumazhisai S. Gunasekaran, Sandeep Gupta, Brad Pasternak, Mark Ellis, Kathryn Peterson, Gary Falk, John Leung, Laurel Prestridge, Michael Hart, Neal Leleiko, Michael Vaezi, Rebecca Cherry, David Katzka, Keith Friedenberg, Yehudith Assouline-Dayan, Vincent Mukkada
BACKGROUND & AIMS: Pharmacologic treatment of eosinophilic esophagitis (EoE) is limited to off-label use of corticosteroids not optimized for esophageal delivery. We performed a randomized, controlled phase 2 trial to assess the ability of budesonide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a271715900994d09ac27e0ad023ef4